Explore CJC-1295 and Ipamorelin Synergy

At Synthesis Peptides, we offer the innovative CJC-1295 without DAC combined with Ipamorelin, forming a powerful blend designed for optimal research efficacy. This peptide synergy is known for its dual-pathway action on Growth Hormone-Releasing Hormone (GHRH) and ghrelin receptor secretagogue mechanisms. For researchers in Las Vegas seeking purity and reliability, our CJC-1295 and Ipamorelin blend undergoes domestic testing via High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry to ensure pristine quality. For detailed information on content and formulation, researchers can choose Synthesis Peptides, where transparency through certificates of analysis is a standard we uphold.

CJC-1295 and Ipamorelin Synergistic Research

Dual-Pathway Mechanisms

The CJC-1295 and Ipamorelin combination works through synergistic dual pathways targeting Growth Hormone-Releasing Hormone (GHRH) receptors and ghrelin receptors. This dual stimulation can lead to increased efficiency in growth hormone release during research.
Dual-Pathway Mechanisms

Precision and Safety in Research

Our CJC-1295 and Ipamorelin blend includes a precise 29-amino acid sequence to ensure integrity in research. Ipamorelin is noted for its selective pulsatile pituitary release properties, minimizing risks of prolactin and cortisol elevation in analytical settings.
Precision and Safety in Research

Third-Party Testing and Analysis

Every batch of our CJC-1295 and Ipamorelin is third-party tested using HPLC and Mass Spectrometry. This ensures the high purity and quality required in professional research environments. The comprehensive Certificates of Analysis guarantee transparency and reliability.
Third-Party Testing and Analysis

Frequently Asked Questions

CJC-1295 functions by stimulating GHRH receptors, enhancing the release of growth hormones, making it valuable for diverse research applications.

Ipamorelin selectively triggers pituitary hormone release without increasing prolactin and cortisol, offering a controlled variable for research purposes.

At Synthesis Peptides, every peptide batch undergoes rigorous third-party testing for purity using HPLC and Mass Spectrometry, accompanied by a Certificate of Analysis to guarantee the integrity needed for research.

Yes, Synthesis Peptides provides Certificates of Analysis for each batch, detailing the exact peptide content and ensuring research-grade quality.

This blend is precisely formulated with CJC-1295's 29-amino acid sequence and Ipamorelin to enhance hormone release through dual pathways without unintended side effects.